COMP <GO>
NAII vs MRK // RETURN ON INVESTED CAPITAL (ROIC)
Natural Alternatives International Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: NAII 0
— MRK 9
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MRK
LAST: $1.07 (-3.60%) • MKT CAP: $6.9M
roic
-10.80%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
roic
20.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NAII VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NAII | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 7.20% | 74.80% | -67.60 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -10.80% | 20.70% | -31.50 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 3.42% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -6.70% | 34.30% | -41.00 | MRK | /operating-margins <GO> |
| Net Profit Margin | -10.50% | 28.10% | -38.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | — | 1.30% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.45 | 5.19 | -3.74 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.9 | 51.7 | -20.80 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.9M | $361.02B | -$361.01B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NAII REV | MRK REV | NAII GROSS % | MRK GROSS % | NAII FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $129.9M | $65.01B | 7.2% | 74.8% | $2.3M | $12.36B |
| FY 2024 | $113.8M | $64.17B | 6.0% | 76.3% | -$4.5M | $18.10B |
| FY 2023 | $0 | $60.12B | — | — | $7.0M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NAII // BETA —
MRK // BETA 0.92